Julie VanOrsdel Daves

Net worth: - $ as of 2024-05-30

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
Jon Root	M	64	EDGEWISE THERAPEUTICS, INC.	5 years
Laura Brege	F	66	EDGEWISE THERAPEUTICS, INC.	4 years
William P. Sheridan	M	69	BIOCRYST PHARMACEUTICALS, INC.	16 years
John Moore	M	59	EDGEWISE THERAPEUTICS, INC.	4 years
R. Carruthers	M	66	EDGEWISE THERAPEUTICS, INC.	4 years
Joanne Donovan	M	67	EDGEWISE THERAPEUTICS, INC.	3 years
Behrad Derakhshan	M	44	EDGEWISE THERAPEUTICS, INC.	4 years

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Michael A. Darwin	M	62	BIOCRYST PHARMACEUTICALS, INC.	8 years
Charlie Sanders	M	91	BIOCRYST PHARMACEUTICALS, INC.	-
Kenneth Harrison	M	44	EDGEWISE THERAPEUTICS, INC.	4 years
Christopher J. Morl	M	65	miRagen Therapeutics, Inc. /Old/ miRagen Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology miRagen Therapeutics, Inc. develops microRNA-based therapeutics for cardiovascular and muscle diseases. It leverages in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance RNA-based technologies and potential drug candidates for its own pipeline and in strategic collaborations. The firm aso focuses on hematological malignancies, fibrosis and neuro inflammation. The company was founded by William S. Marshall, Michael R. Bristow, Marvin H. Caruthers, Bruce Lee Booth and Eric Newell Olson in 2007 and is headquartered in Boulder, CO.	3 years
Robert S. Lowrey	M	63	BIOCRYST PHARMACEUTICALS, INC.	2 years
Stanley Erck	M	76	BIOCRYST PHARMACEUTICALS, INC.	10 years
Michael Jones	M	54	BIOCRYST PHARMACEUTICALS, INC.	13 years
Charles E. Bugg	M	82	BIOCRYST PHARMACEUTICALS, INC.	21 years
Carl Gordon	M	59	BIOCRYST PHARMACEUTICALS, INC.	3 years
David S. McCullough	M	59	BIOCRYST PHARMACEUTICALS, INC.	5 years
Randall B. Riggs	M	57	BIOCRYST PHARMACEUTICALS, INC.	2 years
Randolph Steer	M	74	BIOCRYST PHARMACEUTICALS, INC.	15 years
Keith Leonard	M	62	Sanifit Therapeutics SA Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain.	6 years
J. Claude Bennett	M	90	BIOCRYST PHARMACEUTICALS, INC.	12 years
Elliott T. Berger	M	53	BIOCRYST PHARMACEUTICALS, INC.	14 years
Robert C. Stoner	M	-	BIOCRYST PHARMACEUTICALS, INC.	-
Peter L. McCullough	M	59	BIOCRYST PHARMACEUTICALS, INC.	-
Adam Levy	M	46	Sanifit Therapeutics SA Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain.	-
Pablo Cironi	M	-	Sanifit Therapeutics SA Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain.	3 years
Stuart R. Grant	M	69	BIOCRYST PHARMACEUTICALS, INC.	4 years

Statistics

Country	Connections	% of total
United States	24	88.89%
Spain	3	11.11%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections